PhD in Life Sciences in European Molecular Biology Laboratory – Germany

Summary

The European Molecular Biology Laboratory (EMBL) is offering fully funded PhD positions in Life Sciences through its International PhD Programme (EIPP). These positions are available across multiple EMBL sites including Heidelberg, Barcelona, Grenoble, Hamburg, Hinxton (near Cambridge), and Rome. The program provides comprehensive interdisciplinary training, close mentoring, and creative freedom, fostering early independence and collaborative teamwork. Candidates from diverse backgrounds in Biology, Chemistry, Physics, Mathematics, Computer Science, Engineering, and Molecular Medicine are encouraged to apply. Applicants must hold or anticipate receiving a university degree equivalent to a Master's that qualifies them for a PhD program in the country where the degree was obtained. The deadline for applications is 12 October 2026, with successful candidates expected to start by October 2027. The positions include broad health care and pension benefits.

Key Facts

Position Type	PhD Positions
Discipline	Life Sciences
Research Area	Molecular life sciences, Biology, Chemistry, Physics, Mathematics, Computer Science, Engineering, Molecular Medicine
Degree Required	Master Degree or equivalent
Salary	Fully funded
Funding	Fully Funded PhD Positions
Contract Duration	Temporary
Deadline	2026-10-12
Employer Address	Meyerhofstraße 1, 69117 Heidelberg, Germany
Employer Contact	EMBL Graduate Office

About the Project

The EMBL International PhD Programme offers comprehensive interdisciplinary training focusing on basic research in molecular life sciences. The program provides close mentoring, creative freedom, collaborative teamwork, and individual independence. Research topics are cutting-edge and investigated across various EMBL Research Units.

Key Responsibilities

• Contribute creativity to an international team of scientists
• Focus on basic research in molecular life sciences
• Engage in comprehensive interdisciplinary training
• Participate in collaborative teamwork

Who Should Apply

Candidates with diverse backgrounds in Biology, Chemistry, Physics, Mathematics, Computer Science, Engineering, and Molecular Medicine are encouraged to apply. Applicants must hold or anticipate receiving a university degree that formally qualifies them to enter a PhD or equivalent program in the country where the degree was obtained.

Benefits

• Fully funded PhD positions
• Broad health care benefits
• Pension benefits
• Starting platform for a successful career in science
• Fostering early independence and interdisciplinary research
• Enriching encounter of different nationalities
• Friendly and collaborative atmosphere
• Ideal setting to forge long-lasting connections

About the Employer

The European Molecular Biology Laboratory (EMBL) is an international team of scientists from various disciplines focusing on basic research in molecular life sciences. It operates across multiple sites in Heidelberg, Barcelona, Grenoble, Hamburg, Hinxton (near Cambridge), and Rome. EMBL is a signatory of DORA and implements best practices in research assessment in its recruitment processes. The institution is known for its diverse staff, friendly and collaborative atmosphere, and passion for science.

Frequently Asked Questions

What is the application deadline for these PhD positions?

The application deadline is 12 October 2026.

What are the locations where these PhD positions are offered?

The PhD positions are offered in Heidelberg, Barcelona, Grenoble, Hamburg, Hinxton (near Cambridge), and Rome.

Are these PhD positions fully funded?

Yes, the PhD positions are fully funded and include broad health care and pension benefits.

When would recruited candidates start their work at EMBL?

Recruited candidates would start their work at EMBL latest by October 2027.

What research fields are relevant for these PhD positions?

Relevant research fields include Biological sciences, Chemistry, Computer science, Engineering, Mathematics, Physics, and Molecular Medicine, focusing on molecular life sciences.